Fennec Pharmaceuticals Inc. Common Stock

FENCNASDAQ • USD
6.79 USD
↗ 0.49 (7.78%)AT CLOSE (11:59 AM EDT)
6.80
↗ 0.01 (0.07%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
6.80
↗ 0.01 (0.07%)
🔴Market: CLOSED
Open?$6.46
High?$6.93
Low?$6.22
Prev. Close?$6.30
Volume?216.5K
Avg. Volume?220.2K
VWAP?$6.69
Rel. Volume?0.98x
Bid / Ask
Bid?$5.89 × 100
Ask?$7.73 × 100
Spread?$1.84
Midpoint?$6.81
Valuation & Ratios
Market Cap?234.1M
Shares Out?34.5M
Float?26.9M
Float %?78.6%
P/E Ratio?N/A
P/B Ratio?6.60
EPS?-$0.28
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.37Strong
Quick Ratio?6.23Strong
Cash Ratio?3.50Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
75/100
P/E?
N/A▾
P/B?
6.60FAIR▾
P/S?
5.24FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
-31.5CHEAP▾
EV/Sales?
4.42FAIR▾
Returns & Efficiency
ROE?
-27.5%WEAK▾
ROA?
-13.8%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$197.3M
Related Companies
BMRNKALVEWTXALNYAGIOIRONCPRXCRNXGRCECYTKCAPRDSGNDYNCMMBBBIOFOLDFULCGALTINSMLQDA
News
Profile
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Employees
35
Market Cap
234.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.fennecpharma.com
Listed
2002-01-28
Address
PO BOX 13628
RESEARCH TRIANGLE PARK, NC 27709
Phone: (919) 636-4530
MarketsMoversWatchlist